See the revolutionary technology indicated to reduce harmful contrast (dye) dosage delivered to patients.
DyeVert™ PLUS Contrast Reduction System is a dye management solution for patients with at-risk kidney factors, including:
+ Moderate and severe chronic kidney disease
+ Older age
+ Heart failure
- DyeVert™ PLUS is the only FDA cleared product with the claim of reduced dye delivery to the patient without impacting image quality.
Proven results - DyeVert™ PLUS clinical results show over 40% average reduction in contrast dosage injected to the patient.
Real-time dose monitoring - DyeVert™ PLUS module, smart-syringe and monitor wirelessly communicate real-time contrast monitoring throughout each procedure.
Optimizing procedures for coronary angiography patients at-risk for kidney injury starts with DyeVert PLUS technology.
The DyeVert Plus Technology
DyeVert™ PLUS contrast monitoring system is easy to use and incorporate into common cath-lab procedures.
Uncompromised Imaging: Seeing is Believing
Injections into coronary arteries may result in excess reflux into the aorta that is not needed for imaging. DyeVert™ PLUS reduces contrast amount without compromising image quality. See for yourself.
Without contrast reduction
With DyeVert™ Plus contrast reduction
For more information regarding this product, please complete the form below.
For more information please visit www.ospreymed.com/technology/